Figure 1 | Scientific Reports

Figure 1

From: Blood unconjugated bilirubin and tacrolimus are negative predictors of specific cellular immunity in kidney transplant recipients after SAR-CoV-2 inactivated vaccination

Figure 1

Anti-SARS-CoV-2 antibodies in kidney transplant recipients (KTR) and healthy participants (HPs) at 20 ± 5 days (KTRs1 and HPs1) and 45 ± 10 days (KTRs2 and HPs2) after the second dose of SARS-CoV-2 inactivated vaccine compared with KTRs or HPs without vaccination (KTRs0 and HPs0). (A) The optical density of anti-S1 IgG antibody in KTRs and HPs without vaccination and in 20 ± 5 days and 45 ± 10 days after the second dose of SARS-CoV-2 inactivated vaccine. (B) The optical density of anti-receptor binding ___domain (RBD) IgG antibody in KTRs and HPs without vaccination and in 20 ± 5 days and 45 ± 10 days after the second dose of SARS-CoV-2 inactivated vaccine. (C) The RBD-Angiotensin I Converting Enzyme 2 (ACE2) interaction blocking antibody in KTRs and HPs without vaccination and in 20 ± 5 days and 45 ± 10 days after the second dose of SARS-CoV-2 inactivated vaccine. (D) The optical density of anti-receptor binding ___domain (RBD) IgG antibody in KTRs and HPs without vaccination and in 20 ± 5 days and 45 ± 10 days after the second dose of SARS-CoV-2 inactivated vaccine. The horizontal dotted line indicates the cut-off value for positivity. The cut-off value was calculated using mean + 3 standard deviation (SD) optical density of plasma samples from HPs and KTRs without vaccination.

Back to article page